[Form 4] Apogee Enterprises Inc Insider Trading Activity

Rhea-AI Filing Summary

Procore Technologies, Inc. (PCOR) – Form 144 filing discloses a planned open-market sale of 4,500 common shares by account holder Benjamin C. Singer. The filing, submitted as a LIVE transaction, identifies Morgan Stanley Smith Barney LLC as the executing broker and targets the NYSE on or about 07/10/2025.

Key data:

• Aggregate market value of proposed sale: $337,500 (implied price ≈ $75/share).
• Total shares outstanding: 149,169,227; proposed sale equals roughly 0.003 % of outstanding stock.
• Recent insider activity: the same seller disposed of 4,203 shares on 05/21/2025 for $289,644.28.
• Source of the shares includes performance shares, restricted stock, and ESPP purchases between 05/20/2022 and 05/20/2024.

The form contains the standard attestation that the filer is unaware of undisclosed material adverse information. No relationship to the issuer is specified in the text supplied, and no unusual payment arrangements are noted (cash or “Not Applicable”).

Implications for investors: While the transaction is immaterial to PCOR’s share count, consecutive insider sales within a short window can be interpreted as a modestly negative sentiment signal. Nevertheless, the dollar amount is relatively small for a company of PCOR’s size, and the filing does not reference any company-specific developments.

Positive

• Immaterial size: The 4,500-share sale equals only about 0.003 % of PCOR’s outstanding shares, posing no dilution risk.
• Regulatory transparency: Timely Form 144 filing demonstrates adherence to SEC disclosure rules, giving investors visibility into insider actions.

Negative

• Continued insider selling: Filer also sold 4,203 shares in the previous month, which may signal reduced personal confidence.
• No stated trading plan: Absence of a disclosed Rule 10b5-1 plan may lead investors to question timing motives, albeit certification of no adverse information is provided.

Insights

Securities Analyst

TL;DR Minor Form 144 sale; negligible dilution but continues recent insider selling trend.

The planned 4,500-share disposal represents ≈0.003 % of PCOR’s float—far below thresholds that affect liquidity or earnings per share. However, it follows a 4,203-share sale one month earlier, suggesting the insider is monetising awards earned from performance shares and ESPP purchases. No lock-up expirations or corporate events are referenced, so the sale appears routine. Market impact should be minimal, yet repeated insider selling—even in small lots—can weigh marginally on investor sentiment, particularly if broader fundamentals come into question.

Corporate Governance Expert

TL;DR Routine disposal; governance risk low, but vigilance warranted due to successive trades.

Form 144 filings offer transparency into affiliate transactions. The filer certifies knowledge of no undisclosed adverse information, implying compliance with Rule 10b5-1 safeguards. Given the sale’s tiny proportion of shares outstanding and the absence of complex consideration, governance red flags are limited. Still, consecutive insider trades can raise perception issues unless linked to a pre-arranged trading plan, which is not indicated here. Boards often address this through clearer disclosure policies to maintain investor confidence.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wagner Patricia K

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MN 55435

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/08/2025		G(1)		2,358	D	$0	5,019(2)	D
Common Stock								22,558	I	Family Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person gifted these shares to a trust for the benefit of themselves and their spouse. The reporting person and their spouse are trustees.

2. Includes shares of restricted stock granted under the 2019 Non-Employee Director Stock Plan.

Remarks:

	/s/ Meghan M. Elliott, Attorney-in-Fact for Patricia K. Wagner	07/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many PCOR shares are being sold under this Form 144?

The notice covers 4,500 common shares of Procore Technologies, Inc.

What is the estimated value of the planned PCOR share sale?

The aggregate market value is listed as $337,500.

When is the anticipated sale date for the PCOR shares?

The filer indicates an approximate sale date of 07/10/2025.

What percentage of PCOR’s total shares does the sale represent?

Roughly 0.003 % of the 149,169,227 shares outstanding.

Has the same insider recently sold additional PCOR shares?

Yes. 4,203 shares were sold on 05/21/2025 for $289,644.28.

Which broker is executing the PCOR share sale?

Morgan Stanley Smith Barney LLC, Executive Financial Services division.